. Author manuscript; available in PMC: 2011 Aug 1.

Published in final edited form as: Mol Cancer Ther. 2011 Jan 7;10(2):325–335. doi: 10.1158/1535-7163.MCT-10-0788

Table 2.

EZH2 mRNA levels in SP and non-SP from ovarian tumour ascites samples.

Patient Ascites sample number	Ratio of expression of ABCB1 mRNA SP:non-SP	Ratio of expression of EZH2 mRNA SP:non-SP
6	12.9	14.5^*
7	3.1	4.2^*
9	10.3	1.3
10	2.9	1.3
14	57.6	3.4^*
16	8.4	5.9^*
17	16.9	8.6^*
18	3.7	1.6^*
19	36.8	1.1
21	51.8	2.1^*

significant (p<0.05) difference in EZH2 expression in SP compared to non-SP